Lung Cancer

Lung Cancer

SH 01 - Science Highlights - Lung Cancer

10/22/2018
7:45 AM - 8:15 AM
Location: Room 304

Session Type: Scientific
0.50 AMA PRA Category 1 Credits™
0.50 CAMPEP Credits

This session will offer a summary of the most relevant abstracts from the Lung track
5 - Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Tumors (SABR-COMET): Results of A Randomized Trial
15 - A phase II Trial of Stereotactic Body Radiation Therapy for Operable T1N0M0 Non-Small Cell Lung Cancer. Japan Clinical Oncology Group
(JCOG0403): Long Term Follow-up Results
18 - Toxicity and Local Control in "Ultra-central" Lung Tumors Treated with Stereotactic Body Radiation Therapy (SBRT)
30 - Locally Advanced Non-small Cell Lung Cancer: Excellent Results of Isotoxic Dose Escalation after FDG-PET-guided Target Volume Reduction - Results of a Prospective Randomized Multicenter Trial
184 - Cardiac Events After Radiotherapy (RT) for Stage II-III Non-Small Cell Lung Cancer (NSCLC): Analysis of 748 Patients
189 - Local Ablative Therapy Improves Survival in Patients with Synchronous Oligometastatic NSCLC Harboring EGFR Activating Mutation Treated with First-line EGFR-TKIs

Presentations:


Assets

SH 01 - Science Highlights - Lung Cancer



Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for SH 01 - Science Highlights - Lung Cancer